China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Analysts at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research report issued to clients and investors on Friday. The firm set a “hold” rating on the stock.

China Pharma Stock Performance

Shares of NYSE CPHI opened at $0.19 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. China Pharma has a 1 year low of $0.17 and a 1 year high of $1.16. The firm’s 50 day moving average price is $0.23 and its 200 day moving average price is $0.24.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.